Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 47,784 KARD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Kardigan, Inc. (KARD) | Grant/Award | 47,784 | n/a |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 92,054 | n/a |
| Jan 9, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 2,374 | $171.5K |
| Dec 19, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 56,000 | n/a |
| Aug 5, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 2,245 | $81.3K |
| Jan 9, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 25,000 | n/a |
| Aug 5, 2024 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 25,000 | n/a |
| Jan 23, 2024 | Mirati Therapeutics, Inc. (MRTX) | Disposition to Issuer | 675 | n/a |
| Feb 2, 2023 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 150,000 | n/a |
| Feb 4, 2022 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 166,250 | n/a |